Cargando…

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

INTRODUCTION: Our aim was to develop consensus guidelines for use of recombinant activated factor VII (rFVIIa) in massive hemorrhage. METHODS: A guidelines committee derived the recommendations using clinical trial and case series data identified through searches of available databases. Guidelines w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vincent, Jean-Louis, Rossaint, Rolf, Riou, Bruno, Ozier, Yves, Zideman, David, Spahn, Donat R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750973/ https://www.ncbi.nlm.nih.gov/pubmed/16919168 http://dx.doi.org/10.1186/cc5026

Ejemplares similares

Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials
por: Rizoli, Sandro B, et al.
Publicado: (2006)

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

Management of bleeding following major trauma: a European guideline
por: Spahn, Donat R, et al.
Publicado: (2007)

Correction: Management of bleeding following major trauma: a European guideline
por: Spahn, Donat R, et al.
Publicado: (2007)

Management of bleeding following major trauma: an updated European guideline
por: Rossaint, Rolf, et al.
Publicado: (2010)

Management of bleeding and coagulopathy following major trauma: an updated European guideline
por: Spahn, Donat R, et al.
Publicado: (2013)

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
por: Rossaint, Rolf, et al.
Publicado: (2016)

The STOP the Bleeding Campaign
por: Rossaint, Rolf, et al.
Publicado: (2013)

The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
por: Spahn, Donat R., et al.
Publicado: (2019)

The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition
por: Rossaint, Rolf, et al.
Publicado: (2023)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
por: Goudarzi Pour, Kourosh, et al.
Publicado: (2016)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Recombinant activated coagulation factor VII (rFVIIa) as an adjunctive hemostatic therapy in patients with multiple system organ failure and acute upper gastrointestinal bleeding
por: Milanov, S, et al.
Publicado: (2003)

Successful use of N-acetyl cysteine and activated recombinant factor VII in fulminant hepatic failure and massive bleeding secondary to dengue hemorrhagic fever
por: Manoj, Edirisooriya Maddumage, et al.
Publicado: (2014)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
por: Michalska, G, et al.
Publicado: (2009)

Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma
por: Arora, D, et al.
Publicado: (2011)

Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding
por: Chang, Zhi-gang, et al.
Publicado: (2020)

Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

Correction: Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis
por: Abuhasna, Said D., et al.
Publicado: (2012)

Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding
por: Habib, Aly Makram
Publicado: (2016)

Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma
por: Lee, Ju-Hee, et al.
Publicado: (2009)

A randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (< 48 hours) deaths
por: Rossaint, R, et al.
Publicado: (2005)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
por: Barua, Anupama, et al.
Publicado: (2011)

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation
por: Hollis, Allison L., et al.
Publicado: (2016)

Paradoxical massive pulmonary thromboembolism in a postpartum woman with factor VII deficiency with bleeding tendency: A case report
por: Kang, Donghoon, et al.
Publicado: (2022)

Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia
por: ALMAGRO, D, et al.
Publicado: (2011)

Use of Recombinant Activated Factor VII in Bleeding Lung Transplant Patients Undergoing Perioperative ECMO Therapy †
por: Laxar, Daniel, et al.
Publicado: (2023)

Massive bleeding
por: Federici, Augusto B.
Publicado: (2018)

Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency
por: Seanoon, Karnsasin, et al.
Publicado: (2022)

Massive bleeding in polytrauma: how can we make progress?
por: Vincent, Jean-Louis, et al.
Publicado: (2011)

Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
por: Ng, Heng Joo, et al.
Publicado: (2006)

The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?
por: Altman, Raul, et al.
Publicado: (2010)

Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report
por: Godier, Anne, et al.
Publicado: (2018)

Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)

A review of the recommendations from Chamonix VII
por: Poole, John
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_hls832pbf2j7omhkpghc9fapio